Dr. Kels is a board-certified psychiatrist and an Associate Professor of Psychiatry at UIWSOM. She serves as Chair of the Department of Clinical Sciences. She received her BS in marketing from the Wharton School of the University of Pennsylvania.

Dr. Lori Kels, MD is a psychiatrist in San Antonio, TX and has over 10 years of experience in the medical field. She graduated from University of Nevada, Reno School of Medicine in 2010. She is affiliated with George Washington University Hospital. She is accepting new patients.

Dr. Lori H. Kels is a psychiatrist in Brooks City Base, Texas. She received her medical degree from University of Nevada Reno School of Medicine and has been in practice between 11-20 years....

Dr. Lori Kels is an Assistant Professor of Psychiatry in the Department of Clinical and Applied Science Education at UIWSOM. She received her BS in marketing from the Wharton School of the University of Pennsylvania.

Lori Kels is a concerned and interested psychiatrist serving the community of New Washington, DC. Dr. Kels attended medical school at the University of Nevada. She completed her residency in psychiatry at George Washington University. Dr. Kels is affiliated with the George Washington University Hospital in Washington, DC.

Dr. Lori Kels is a psychiatrist with the George Washington University Medical Faculty Associates. Dr. Kels completed her undergraduate degree at the University of Pennsylvania and...

Dr. Lori Kels, MD is a psychiatrist in San Antonio, TX. She currently practices at Practice and is affiliated with George Washington University Hospital. She accepts multiple insurance plans. Dr. Kels is board certified in Psychiatry.

Dr. Lori Kels, MD is a Psychiatrist in San Antonio, TX. Explore Dr. Kels' background and schedule appointments with Medical News Today.

Jun 15, 2023 · There are many effective and well-tolerated treatment options for most patients experiencing major depressive episodes, but for patients with treatment-resistant major depressive disorder or bipolar depression, current pharmacologic and non-pharmacologic options can be less efficacious, well tolerated, or accessible.